Classifying Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia Hemodynamics Matter

被引：1
|
作者：
Roman, Beth L. [1 ]
Cuttica, Michael J. [2 ]
机构：
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA
[2] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 196卷 / 10期
关键词：
MUTATIONS; RECEPTOR;
D O I：
10.1164/rccm.201704-0765ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1244 / 1246
页数：4
相关论文
共 50 条
  • [21] IT'S NOT ALWAYS EASY TO CLASSIFY PULMONARY HYPERTENSION - A CASE OF HEREDITARY HEMORRHAGIC TELANGIECTASIA
    Aguirre Villarreal, David
    Payro, Gerardo
    Leal Villarreal, Mario Andres De Jesus
    Cesar Cazares Diazleal, Aldo
    Manuel Garcia Garcia, Hector
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3130 - 3130
  • [22] Ammonia Predicts Hepatic Involvement and Pulmonary Hypertension in Patients With Hereditary Hemorrhagic Telangiectasia
    Bloom, Patricia P.
    Rodriguez-Lopez, Josanna
    Witkin, Alison S.
    Al-Samkari, Hanny
    Kuter, David J.
    Mojtahed, Amirkasra
    Luther, Jay
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 : e00118
  • [23] Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia
    Chang, Sung-A
    Jang, Shin Yi
    Ki, Chang-Seok
    Kang, I-Seok
    Kim, Duk-Kyung
    HEART AND VESSELS, 2011, 26 (02) : 231 - 234
  • [24] Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia Related to an ACVRL1 Mutation
    Yokokawa, Tetsuro
    Sugimoto, Koichi
    Kimishima, Yusuke
    Misaka, Tomofumi
    Yoshihisa, Akiomi
    Morisaki, Hiroko
    Yamada, Osamu
    Nakazato, Kazuhiko
    Ishida, Takafumi
    Takeishi, Yasuchika
    INTERNAL MEDICINE, 2020, 59 (02) : 221 - 227
  • [25] Prominent Bronchial Artery Contributing To Pulmonary Hypertension In A Patient With Hereditary Hemorrhagic Telangiectasia
    Li, N.
    Poor, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [26] Bevacizumab (Avastin) treatment for severe pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
    Mei-Zahav, M.
    Rosengarten, D.
    Issachar, A.
    Blau, H.
    Stemmer, S.
    Kramer, M.
    ANGIOGENESIS, 2018, 21 (01) : 118 - 119
  • [27] Pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia successfully treated with sildenafil
    Miyake, Ryo
    Fujino, Takeo
    Abe, Kohtaro
    Hosokawa, Kazuya
    Ohtani, Kisho
    Morisaki, Hiroko
    Yamada, Osamu
    Higo, Taiki
    Ide, Tomomi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 214 : 276 - 277
  • [28] Pulmonary Arterial Hypertension: An Important and Sometimes Hidden Manifestation of Hereditary Hemorrhagic Telangiectasia
    Trujillo, C. J.
    Knott, E.
    Barrios, M. Schweitzer
    Khalid, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [29] Outcomes following lung transplantation for pulmonary hypertension secondary to hereditary hemorrhagic telangiectasia
    Kim, J.
    Studer, S. M.
    Crespo, M. M.
    Pilewski, J.
    Toyoda, Y.
    Johnson, B. A.
    Oggionni, T.
    Vitulo, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S82 - S82
  • [30] Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia
    Sung-A Chang
    Shin Yi Jang
    Chang-Seok Ki
    I-Seok Kang
    Duk-Kyung Kim
    Heart and Vessels, 2011, 26 : 231 - 234
12345